Study of Oral Oteseconazole (VT-1161) for Acute Yeast Infections in Patients With Recurrent Yeast Infections
Public ClinicalTrials.gov record NCT03840616. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3, Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Oteseconazole (VT-1161) Oral Capsules vs Fluconazole and Placebo in Treatment of Acute Vulvovaginal Candidiasis in Subjects With Recurrent Vulvovaginal Candidiasis
Study identification
- NCT ID
- NCT03840616
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Mycovia Pharmaceuticals Inc.
- Industry
- Enrollment
- 219 participants
Conditions and interventions
Conditions
Interventions
- Oteseconazole (VT-1161) 150mg capsule Drug
- Fluconazole 150mg capsule Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 12, 2019
- Primary completion
- Dec 1, 2020
- Completion
- Dec 1, 2020
- Last update posted
- Feb 3, 2022
2019 – 2020
United States locations
- U.S. sites
- 33
- U.S. states
- 17
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 34 | Tucson | Arizona | 85712 | — |
| 39 | Encino | California | 91436 | — |
| 25 | Los Angeles | California | 90036 | — |
| 22 | Englewood | Colorado | 80112 | — |
| 49 | Boca Raton | Florida | 33486 | — |
| 14 | Gainesville | Florida | 32607 | — |
| 13 | Leesburg | Florida | 34748 | — |
| 33 | Loxahatchee Groves | Florida | 33470 | — |
| 36 | Miami | Florida | 33155 | — |
| 17 | Savannah | Georgia | 31406 | — |
| 27 | Idaho Falls | Idaho | 83404 | — |
| 10 | Nampa | Idaho | 83687 | — |
| 62 | Chicago | Illinois | 60643 | — |
| 41 | Fort Wayne | Indiana | 46825 | — |
| 30 | Marrero | Louisiana | 70072 | — |
| 50 | Dearborn Heights | Michigan | 48127 | — |
| 29 | Saginaw | Michigan | 48602 | — |
| 55 | Traverse City | Michigan | 49686 | — |
| 32 | Troy | Michigan | 48085 | — |
| 26 | Kansas City | Missouri | 64111 | — |
| 42 | New Brunswick | New Jersey | 08901 | — |
| 47 | Ocean City | New Jersey | 07712 | — |
| 37 | Charlotte | North Carolina | 28207 | — |
| 38 | Fayetteville | North Carolina | 28304 | — |
| 15 | Columbus | Ohio | 43213 | — |
| 18 | Bluffton | South Carolina | 29910 | — |
| 48 | Myrtle Beach | South Carolina | 29572 | — |
| 20 | Bristol | Tennessee | 37620 | — |
| 21 | Murfreesboro | Tennessee | 37130 | — |
| 24 | Austin | Texas | 78705 | — |
| 23 | Fort Worth | Texas | 76104 | — |
| 63 | Katy | Texas | 77450 | — |
| 58 | League City | Texas | 77573 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03840616, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 3, 2022 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03840616 live on ClinicalTrials.gov.